Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamibarotene in Alzheimer's Disease
NCT01120002Phase 2Unknown
- Sponsor
- Osaka City University
- Start
- May 2010
- Primary completion
- Dec 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of tamibarotene in Alzheimer's disease (AD), sponsored by Osaka City University. Status: unknown.
02
Drugs
tamibarotene
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01120002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01120002.